Benitec Biopharma Inc. (BNTC): 8 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Dec 29, 2025 | Cowen Aaron Director, TenPercentOwner | 144,223 | $13.20 | $1.9M | no history |
| Dec 22, 2025 | Averill Madison Master Fund, Ltd. TenPercentOwner | 46,141 | $11.68 | $539.0K | no history |
| Nov 10, 2025 | Suvretta Capital Management, Llc Director, TenPercentOwner | 1,481,481 | $13.50 | $20.0M | no history |
| Apr 2, 2025 | Suvretta Capital Management, Llc Director, TenPercentOwner | 16,497 | $12.83 | $211.7K | no history |
| Mar 28, 2025 | Cowen Aaron TenPercentOwner | 900,000 | $13.00 | $11.7M | no history |
| Dec 26, 2024 | Cowen Aaron TenPercentOwner | 47,520 | $11.09 | $527.2K | no history |
| Dec 5, 2024 | Suvretta Capital Management, Llc Director, TenPercentOwner | 42,000 | $9.60 | $403.2K | no history |
| Nov 21, 2024 | Averill Master Fund, Ltd. Director, TenPercentOwner | 41,436 | $10.05 | $416.6K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.